Muthoni Mwaura
Maastricht, LI, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Effectiveness and safety of 7-day high-dose primaquine and single-dose tafenoquine versus 14-day low-dose primaquine in patients with Plasmodium vivax malaria (EFFORT): a multicentre, open-label, randomised, controlled, superiority trial.
Journal: The Lancet. Infectious diseases
Published: September 04, 2025
Risk perceptions of high-dose primaquine and tafenoquine among Plasmodium vivax malaria stakeholders in Ethiopia: a qualitative study.
Journal: BMJ global health
Published: September 02, 2025
Co-design of a routine clinical review to improve the safety of high dose radical cure treatment for Plasmodium vivax malaria: findings from Cambodia and Ethiopia.
Journal: Malaria journal
Published: December 20, 2024
How do study participants want to be informed about study results: Findings from a malaria trial in Cambodia, Ethiopia, Pakistan, and Indonesia.
Journal: Journal of clinical and translational science
Published: September 09, 2024
A Review of the Current Status of G6PD Deficiency Testing to Guide Radical Cure Treatment for Vivax Malaria.
Journal: Pathogens (Basel, Switzerland)
Published: March 29, 2023
Constructing confidence: User perspectives on AlereLAM testing for tuberculosis.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: July 23, 2021
Situating trade-offs: Stakeholder perspectives on overtreatment versus missed diagnosis in transition to Xpert MTB/RIF Ultra in Kenya and Swaziland.
Journal: PloS one
Published: October 04, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026